Amjevita Approved to Treat Inflammatory Diseases

MONDAY, Sept. 26, 2016 — Amjevita (adalimumab-atto) — a biosimilar drug similar to the popular anti-inflammatory drug Humira — has been approved by the U.S. Food and Drug Administration.
Amjevita has been approved for moderate-to-severe…
Source: Topamax